^
Association details:
| Biomarker: | KRAS G12C |
|---|---|
| Cancer: | Colon Cancer |
| Drug: | Erbitux (cetuximab) (EGFR inhibitor) + Lumakras (sotorasib) (KRAS G12C inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
09/21/2023
Excerpt:
Colon Cancer: SYSTEMIC THERAPY FOR ADVANCED OR METASTATIC DISEASE...Sotorasib + cetuximab (KRAS G12C mutation positive)…
